Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

被引：0
|
作者：
Michael V. Chiorean
Jessica R. Allegretti
Puza P. Sharma
Benjamin Chastek
Leonardo Salese
Elizabeth J. Bell
Jesse Peterson-Brandt
Joseph C. Cappelleri
Xiang Guo
Nabeel Khan
机构：
[1] Swedish Medical Center,Perelman School of Medicine
[2] Brigham and Women’s Hospital,undefined
[3] Pfizer Inc,undefined
[4] Optum Life Sciences,undefined
[5] HEOR,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
[8] University of Pennsylvania,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] REAL-WORLD EXPERIENCE WITH TOFACITINIB DOSE DE-ESCALATION IN PATIENTS WITH MODERATE AND SEVERE ULCERATIVE COLITIS
    Yu, Amy
    Shi, Bingyan
    Ha, Nghiem
    Beck, Kendall
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S80 - S80
  • [12] Real world use of adalimumab: effects on corticosteroid treatment and hospital resource utilisation in UK patients with moderate/severe ulcerative colitis
    Watts, G.
    Arasaradnam, R.
    Travis, S.
    Sharma, A.
    Awasthi, A.
    Limdi, J.
    Bishop-Bailey, A.
    Mclain-Smith, S.
    Finney-Hayward, T.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S340 - S341
  • [13] EARLY 'REAL WORLD' EXPERIENCE WITH TOFACITINIB FOR MODERATE TO SEVERE ULCERATIVE COLITIS
    Honap, Sailish
    Sharma, Esha
    Ray, Shuvra
    Cunningham, Georgina
    Tamilarasan, Aravind
    Mawdsley, Joel
    Anderson, Simon
    Sanderson, Jeremy
    Irving, Peter
    GUT, 2019, 68 : A78 - A79
  • [14] CLINICAL CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION IN A REAL-WORLD COHORT OF PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB
    Chiorean, Michael V.
    Sharma, Puza P.
    Salese, Leonardo
    Gruben, David
    Woolcott, John
    Khan, Nabeel
    GASTROENTEROLOGY, 2021, 160 (06) : S229 - S230
  • [15] Real-world experience of tofacitinib in Australia for treatment of ulcerative colitis
    Khoo, E.
    Lee, A.
    Lo, S. W.
    Wright, E.
    Ghaly, S.
    Makanyanga, J.
    Thin, L.
    Fang, W.
    Niewiadomski, O.
    Chung, A.
    Digby-Bell, J.
    Sparrow, M.
    Shelton, E.
    Jakobovits, S.
    Scott, D.
    Ward, M.
    Ardalan, Z. S. M.
    An, Y-K
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 124 - 125
  • [16] Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis
    Kojima, Kentaro
    Watanabe, Kenji
    Kawai, Mikio
    Yagi, Soichi
    Kaku, Koji
    Ikenouchi, Maiko
    Sato, Toshiyuki
    Kamikozuru, Koji
    Yokoyama, Yoko
    Takagawa, Tetsuya
    Shimizu, Masahito
    Shinzaki, Shinichiro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (13) : 1871 - 1886
  • [17] Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
    Deepak, Parakkal
    Alayo, Quazim A.
    Khatiwada, Aava
    Lin, Bixuan
    Fenster, Marc
    Dimopoulos, Christina
    Bader, Geoffrey
    Weisshof, Roni
    Jacobs, Michael
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    Christophi, George P.
    Patel, Anish
    Hirten, Robert P.
    Colombel, Jean-Frederic
    Rubin, David T.
    Ha, Christina
    Beniwal-Patel, Poonam
    Ungaro, Ryan C.
    Syal, Gaurav
    Pekow, Joel
    Cohen, Benjamin L.
    Yarur, Andres
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1592 - +
  • [18] Real-World Experience of Upadacitinib in Treatment of Adults With Moderate to Severe Ulcerative Colitis
    Chowla, Navreet M.
    Tariq, Raseen
    Aggarwal, Manik
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S820
  • [19] REAL-WORLD EFFECTIVENESS OF TOFACITINIB FOR MODERATE TO SEVERE ULCERATIVE COLITIS: A MULTI-CENTRE UK EXPERIENCE
    Chapman, Thomas
    Chee, Desmond
    Honap, Sailish
    Patel, Mehul
    Kent, Alexandra
    Ray, Shuvra
    Sharma, Esha
    Kennedy, James
    Cripps, Sarah
    Walsh, Alissa
    Goodhand, James
    Ahmad, Tariq
    Satsangi, Jack
    Irving, Peter
    Kennedy, Nicholas
    GUT, 2021, 70 : A88 - A88
  • [20] Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study
    Hoffmann, Peter
    Globig, Anna-Maria
    Thomann, Anne K.
    Grigorian, Maximilian
    Krisam, Johannes
    Hasselblatt, Peter
    Reindl, Wolfgang
    Gauss, Annika
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 13
12345